Clinical trials
Observational Hematologic Diseases trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 6 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 5 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gruppo Italiano Trapianto di Midollo Osseo | 4 |
| Swedish Orphan Biovitrum | 2 |
| Azienda Ospedaliera San Giovanni Battista | 1 |
| Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| BioMarin Pharmaceutical | 1 |
| Boston Children's Hospital | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
| Hospital Universitari Vall d'Hebron Research Institute | 1 |
| Istituto Clinico Humanitas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 18 |
| Blood Coagulation Disorders | 4 |
| Coagulation Protein Disorders | 3 |
| Genetic Diseases, Inborn | 3 |
| Hemorrhagic Disorders | 3 |
| Blood Coagulation Disorders, Inherited | 2 |
| Hematologic Neoplasms | 2 |
| Hemophilia A | 2 |
| Hemophilia B | 2 |
| Anemia | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.